|
|
Suppliers for
Oxaliplatin
|
Properties | CAS |
61825-94-3 | Formula |
C8H14N2O4Pt |
|
|
26 Registered suppliers
Molecular Formula: C6H14N2.C2O4.Pt Molecular Weight: 397,29
More details are to be found here
Molecular Formula: C6H14N2.C2O4.Pt Molecular Weight: 397,29
More details are to be found here
Molecular Formula: C6H14N2.C2O4.Pt Molecular Weight: 397,29
More details are to be found here
Molecular Formula: C6H14N2.C2O4.Pt Molecular Weight: 397,29
More details are to be found here
More details are to be found here
More details are to be found here
Description : Oxaliplatin is a platinum-based antineoplastic agent used in cancer chemotherapy that inhibits DNA synthesis by conforming DNA adducts in cancer cells. - Molecular Weight :397.29
- Melting Point :> 196°C (dec.)
- Purity :> 98%
Molecular Formula : C8H14N2O4Pt Canonical SMILES : O=C1[O-][Pt+2]2([O-]C1=O)[NH2]C3CCCCC3[NH2]2 InChI : InChI=1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;+2/p-2/t5-,6-;;/m1../s1 InChIKey : ZROHGHOFXNOHSO-BNTLRKBRSA-L Solubility : Soluble in DMSO (Sparingly), Methanol (Very Slightly), Water (Slightly) Appearance : White to Off-white Solid Storage : Store at -20°C Synonyms : Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-; (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum; 1,2-Cyclohexanediamine, platinum complex, (1R-trans)-; Platinum, (1,2-cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']-, [SP-4-2-(1R-trans)]-; Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN,κN'][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-; Dacplat; Eloxatin; Elplat; l-OHP; Lipoxal; NSC 266046; Oxalato(trans-l-1,2-cyclohexanediamine)platinum(II); Oxalato[trans-(-)-1,2-cyclohexanediamine]platinum(II); Oxalatoplatin; Oxalatoplatinum; Platinum, (1,2-cyclohexanediamine-κN,κN')[ethanedioato(2-)-κO1,κO2]-, [SP-4-2-(1R-trans)]-; RP 54780; trans-L-Diaminocyclohexane oxalatoplatinum
More details are to be found here
Description : Oxaliplatin is a platinum-based antineoplastic agent used in cancer chemotherapy that inhibits DNA synthesis by conforming DNA adducts in cancer cells. - Molecular Weight :397.29
- Melting Point :> 196°C (dec.)
- Purity :> 98%
Molecular Formula : C8H14N2O4Pt Canonical SMILES : O=C1[O-][Pt+2]2([O-]C1=O)[NH2]C3CCCCC3[NH2]2 InChI : InChI=1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;+2/p-2/t5-,6-;;/m1../s1 InChIKey : ZROHGHOFXNOHSO-BNTLRKBRSA-L Solubility : Soluble in DMSO (Sparingly), Methanol (Very Slightly), Water (Slightly) Appearance : White to Off-white Solid Storage : Store at -20°C Synonyms : Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-; (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum; 1,2-Cyclohexanediamine, platinum complex, (1R-trans)-; Platinum, (1,2-cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']-, [SP-4-2-(1R-trans)]-; Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN,κN'][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-; Dacplat; Eloxatin; Elplat; l-OHP; Lipoxal; NSC 266046; Oxalato(trans-l-1,2-cyclohexanediamine)platinum(II); Oxalato[trans-(-)-1,2-cyclohexanediamine]platinum(II); Oxalatoplatin; Oxalatoplatinum; Platinum, (1,2-cyclohexanediamine-κN,κN')[ethanedioato(2-)-κO1,κO2]-, [SP-4-2-(1R-trans)]-; RP 54780; trans-L-Diaminocyclohexane oxalatoplatinum
More details are to be found here
Description : Oxaliplatin is a platinum-based antineoplastic agent used in cancer chemotherapy that inhibits DNA synthesis by conforming DNA adducts in cancer cells. - Molecular Weight :397.29
- Melting Point :> 196°C (dec.)
- Purity :> 98%
Molecular Formula : C8H14N2O4Pt Canonical SMILES : O=C1[O-][Pt+2]2([O-]C1=O)[NH2]C3CCCCC3[NH2]2 InChI : InChI=1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;+2/p-2/t5-,6-;;/m1../s1 InChIKey : ZROHGHOFXNOHSO-BNTLRKBRSA-L Solubility : Soluble in DMSO (Sparingly), Methanol (Very Slightly), Water (Slightly) Appearance : White to Off-white Solid Storage : Store at -20°C Synonyms : Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-; (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum; 1,2-Cyclohexanediamine, platinum complex, (1R-trans)-; Platinum, (1,2-cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']-, [SP-4-2-(1R-trans)]-; Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN,κN'][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-; Dacplat; Eloxatin; Elplat; l-OHP; Lipoxal; NSC 266046; Oxalato(trans-l-1,2-cyclohexanediamine)platinum(II); Oxalato[trans-(-)-1,2-cyclohexanediamine]platinum(II); Oxalatoplatin; Oxalatoplatinum; Platinum, (1,2-cyclohexanediamine-κN,κN')[ethanedioato(2-)-κO1,κO2]-, [SP-4-2-(1R-trans)]-; RP 54780; trans-L-Diaminocyclohexane oxalatoplatinum
More details are to be found here
Purity : 98% Smile code : O=C1O[Pt]2([NH2][C@@H]3CCCC[C@H]3[NH2]2)OC1=O MDL Number : MFCD00866327 MolFormula : C8H14N2O4Pt MolWeight : 397.2858 Available in stock : 49.393
More details are to be found here
Purity : 98% Smile code : O=C1O[Pt]2([NH2][C@@H]3CCCC[C@H]3[NH2]2)OC1=O MDL Number : MFCD00866327 MolFormula : C8H14N2O4Pt MolWeight : 397.2858 Available in stock : 49.393
More details are to be found here
Purity : 98% Smile code : O=C1O[Pt]2([NH2][C@@H]3CCCC[C@H]3[NH2]2)OC1=O MDL Number : MFCD00866327 MolFormula : C8H14N2O4Pt MolWeight : 397.2858 Available in stock : 49.393
More details are to be found here
Purity : 98% Smile code : O=C1O[Pt]2([NH2][C@@H]3CCCC[C@H]3[NH2]2)OC1=O MDL Number : MFCD00866327 MolFormula : C8H14N2O4Pt MolWeight : 397.2858 Available in stock : 49.393
More details are to be found here
Purity : 98% Smile code : O=C1O[Pt]2([NH2][C@@H]3CCCC[C@H]3[NH2]2)OC1=O MDL Number : MFCD00866327 MolFormula : C8H14N2O4Pt MolWeight : 397.2858 Available in stock : 49.393
More details are to be found here
OXALIPLATIN is an enantiomerically pure platinum-based antineoplastic agent (inhibition of cell proliferation) used in cancer chemotherapy.
THERAPEUTIC INDICATION: ONCOLOGY
OXALIPLATIN is used for the treatment of colorectal cancer, typically along with Folinic acid and 5-fluorouracil in a combination known as FOLFOX. It has been compared to other Pt- compounds used for advanced cancers, such as Cisplatin and Carboplatin. A combination with the mono-clonal antibody Bevacizumab increases its activity.
MARKET INFORMATION
Originator: SANOFI-AVENTIS
Originator product: ELOXATIN®
YOUR ADVANTAGES
- Manufactured in China by a reliable supplier
- Good quality product with matching EP & JP quality
- USP is based on a different process
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
|
Properties:
... more properties and specification on Oxaliplatin
|
|
Privileged suppliers
Last update 2024-05-03
|